Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Endocrinology|November 27, 2001
Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunitsL Cobellis, P Cataldi, F M Reis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 20, 2015
How often parametrial involvement leads to post-operative adjuvant treatment in locally advanced cervical cancer after neoadjuvant chemotherapy and type C radical hysterectomy?F Martinelli, G Bogani, A Ditto, et al.
European Journal of Gynaecological Oncology|May 16, 2002
Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of doseA Cerrotta, G Gardan, R Cavina, et al.
The International Journal of Biological Markers|October 1, 1988
Changes in receptor status after treatment with tamoxifen in endometrial cancerS Oriana, F Raspagliesi, P G Duca, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 12, 2014
Class II versus Class III radical hysterectomy in early cervical cancer: an observational study in a tertiary centerA Ditto, F Martinelli, S Ramondino, et al.
Tumori|August 16, 2001
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical studyM Deraco, C R Rossi, E Pennacchioli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Potentials of cell kinetics in the management of patients with ovarian cancersR Silvestrini, M G Daidone, B Valentinis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 11, 2022
Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancerU Leone Roberti Maggiore, G Bogani, F Martinelli, et al.
The International Journal of Biological Markers|January 1, 1986
Usefulness and potential pitfalls of sialic acid determination in sera of patients with ovarian tumorsB Berra, S Rapelli, G Monticelli, et al.
British Journal of Cancer|May 1, 1994
The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot studyA Di Leo, E Bajetta, F Nolè, et al.
Pageof 7